In line with these data, Fiegler et al. (35) have recently shown that B7-H6 expression is downregulated in various tumor cell lines upon treatment with histone deacetylase (HDAC) inhibitors or after siRNA-mediated knockdown of HDAC-2 or -3. This evidence concerns the gene NCR3LG1 and neoplasm.